Search - tctmd.com

Displaying 101 - 120 of 128

Sort: Relevancy | Date

Presentation THT Abstracts 2024

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Presenter: Carl Pepine

March 04, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation THT Abstracts 2024

Hemodynamic Response Related to Stimulation of the Greater Splanchnic Nerve Pre- and Post- Ablation

Presenter: Luke Kim

March 04, 2024

Presentation THT Abstracts 2024

ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD)

Presenter: Brent Medoff

March 04, 2024

Presentation THT Abstracts 2024

Impact of Cardiogenic Shock Progression on Outcomes: SCAI B is Bad 2013 A Cardiogenic Shock Working Group Report

Presenter: Van-Khue Ton

March 04, 2024

Presentation THT Abstracts 2024

Three-Dimensional Morphological Analysis por Percutaneous Closure Candidate Selection and In-Hospital Mortality Prediction in Ischemic Ventricular Septal Ruptures

Presenter: Eduardo Arias

March 04, 2024

Presentation THT Abstracts 2024

Three Phenotypes of High-Risk PCI Patients - Insights from the PROTECT III Registry

Presenter: Guillaume Bonnet

March 04, 2024

Presentation THT Abstracts 2024

IV Diltiazem Use in Patients with Atrial Fibrillation and Systolic Dysfunction

Presenter: Joseph Ibrahim

March 04, 2024

Presentation THT Abstracts 2024

In-Hospital Mortality Rate and Predictors of 30-Day Readmission in Patients with Heart Failure and HIV disease-A Cross Sectional Study from Nationwide Readmission Database

Presenter: Badri Aryal

March 04, 2024

Presentation THT Abstracts 2024

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Presenter: Charles Sherrod

March 04, 2024

Presentation THT Abstracts 2024

Unloading Effect of Intra-aortic balloon pump and Impella in Venoarterial ECMO Patients

Presenter: Fouad Sakr

March 04, 2024

Presentation THT Abstracts 2024

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Presenter: Nadira Hamid

March 04, 2024

Presentation THT Abstracts 2024

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Presenter: Sheldon Litwin

March 04, 2024

Presentation THT Abstracts 2024

Investigating the Efficacy of Transfer Learning for the Detection of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Patients: An Experimental Approach †

Presenter: Kyung-Hee Kim

March 04, 2024

Presentation THT Abstracts 2024

Enhanced Cardiac Support and Reduced Risks: Evaluating Impella 5.5 in ECPELLA Therapy

Presenter: Ameesh Isath

March 04, 2024

Presentation THT Abstracts 2024

Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation

Presenter: Robert Zilinyi

March 04, 2024

Presentation THT Abstracts 2024

Accuracy and Consistency of Online Chat-based Artificial Intelligence Platforms in Answering Patients' 2019 Questions About Heart Failure

Presenter: Elie Kozaily

March 04, 2024

Presentation THT Abstracts 2024

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: JoAnn Lindenfeld

March 04, 2024

Presentation THT Abstracts 2024

Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Presenter: William Abraham

March 04, 2024

Presentation THT Abstracts 2024

Temporal Trends of Vasopressor and Inotrope Use in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Presenter: Saraschandra Vallabhajosyula

March 04, 2024

Advertisement

First in Man CardiALLO NK1R+ MSC Phase I/II Trial in Ischemic NYHA II and III HFrEF

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Hemodynamic Response Related to Stimulation of the Greater Splanchnic Nerve Pre- and Post- Ablation

ImpellaÆ Use Improves Hemodynamics for Cardiogenic Shock from Ventricular Septal Defect (VSD)

Impact of Cardiogenic Shock Progression on Outcomes: SCAI B is Bad 2013 A Cardiogenic Shock Working Group Report

Three-Dimensional Morphological Analysis por Percutaneous Closure Candidate Selection and In-Hospital Mortality Prediction in Ischemic Ventricular Septal Ruptures

Three Phenotypes of High-Risk PCI Patients - Insights from the PROTECT III Registry

IV Diltiazem Use in Patients with Atrial Fibrillation and Systolic Dysfunction

In-Hospital Mortality Rate and Predictors of 30-Day Readmission in Patients with Heart Failure and HIV disease-A Cross Sectional Study from Nationwide Readmission Database

Association Between Frailty and Outcomes of Transcatheter Edge-to-Edge Repair in Functional Mitral Regurgitation: Results from the COAPT trial

Unloading Effect of Intra-aortic balloon pump and Impella in Venoarterial ECMO Patients

Association of a Novel, Non-invasive AI Model to Automate Echocardiographic Detection of Heart Failure with Preserved Ejection Fraction (HFpEF) with Invasive Hemodynamics

Endovascular Ablation of the Right Greater Splanchnic Nerve in Heart Failure with Preserved Ejection Fraction: Differences in Medication Changes in in the Sham and Treatment groups of REBALANCE-HF

Investigating the Efficacy of Transfer Learning for the Detection of Left Ventricular Systolic Dysfunction in Left Bundle Branch Block Patients: An Experimental Approach †

Enhanced Cardiac Support and Reduced Risks: Evaluating Impella 5.5 in ECPELLA Therapy

Factors Associated with Survival-to-Discharge in Patients with High-Risk Pulmonary Embolism Requiring Extracorporeal Membrane Oxygenation

Accuracy and Consistency of Online Chat-based Artificial Intelligence Platforms in Answering Patients' 2019 Questions About Heart Failure

Long-Term Quality of Life Response Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Utilization of Advanced Heart Failure Interventions Observed in the Baroreflex Activation Therapy for Heart Failure (BeAT-HF) Trial

Temporal Trends of Vasopressor and Inotrope Use in Cardiogenic Shock: A Cardiogenic Shock Working Group Report

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content